1. Home
  2. SWKH vs CVRX Comparison

SWKH vs CVRX Comparison

Compare SWKH & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWKH
  • CVRX
  • Stock Information
  • Founded
  • SWKH 1996
  • CVRX 2000
  • Country
  • SWKH United States
  • CVRX United States
  • Employees
  • SWKH N/A
  • CVRX N/A
  • Industry
  • SWKH Diversified Financial Services
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SWKH Finance
  • CVRX Health Care
  • Exchange
  • SWKH Nasdaq
  • CVRX Nasdaq
  • Market Cap
  • SWKH 176.0M
  • CVRX 203.9M
  • IPO Year
  • SWKH 1999
  • CVRX 2021
  • Fundamental
  • Price
  • SWKH $14.45
  • CVRX $8.64
  • Analyst Decision
  • SWKH Strong Buy
  • CVRX Buy
  • Analyst Count
  • SWKH 1
  • CVRX 7
  • Target Price
  • SWKH $18.00
  • CVRX $14.00
  • AVG Volume (30 Days)
  • SWKH 7.0K
  • CVRX 199.5K
  • Earning Date
  • SWKH 11-13-2025
  • CVRX 10-28-2025
  • Dividend Yield
  • SWKH N/A
  • CVRX N/A
  • EPS Growth
  • SWKH 55.18
  • CVRX N/A
  • EPS
  • SWKH 1.41
  • CVRX N/A
  • Revenue
  • SWKH $37,409,000.00
  • CVRX $54,652,000.00
  • Revenue This Year
  • SWKH $52.93
  • CVRX $11.32
  • Revenue Next Year
  • SWKH N/A
  • CVRX $18.58
  • P/E Ratio
  • SWKH $10.21
  • CVRX N/A
  • Revenue Growth
  • SWKH 47.31
  • CVRX 23.11
  • 52 Week Low
  • SWKH $12.00
  • CVRX $4.30
  • 52 Week High
  • SWKH $16.24
  • CVRX $18.55
  • Technical
  • Relative Strength Index (RSI)
  • SWKH 46.81
  • CVRX 65.01
  • Support Level
  • SWKH $14.35
  • CVRX $7.52
  • Resistance Level
  • SWKH $15.15
  • CVRX $8.94
  • Average True Range (ATR)
  • SWKH 0.22
  • CVRX 0.44
  • MACD
  • SWKH -0.00
  • CVRX 0.14
  • Stochastic Oscillator
  • SWKH 16.25
  • CVRX 85.98

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: